Figlerowicz M - Search Results

1

Factors influencing early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin.

Kowala-Piaskowska A, Słuzewski W, Figlerowicz M, Mozer-Lisewska I. Kowala-Piaskowska A, et al. Among authors: figlerowicz m. Hepatol Res. 2005 Aug;32(4):224-6. doi: 10.1016/j.hepres.2005.05.004. Epub 2005 Aug 8. Hepatol Res. 2005. PMID: 16087393

2

Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C.

Mozer-Lisewska I, Słuzewski W, Ali Youseif K, Figlerowicz M, Kowala-Piaskowska A. Mozer-Lisewska I, et al. Among authors: figlerowicz m. Eur J Pediatr. 2003 Nov;162(11):755-9. doi: 10.1007/s00431-002-1147-x. Epub 2003 Aug 22. Eur J Pediatr. 2003. PMID: 12937972

3

Interferon alpha and ribavirin in the treatment of children with chronic hepatitis C.

Figlerowicz M, Sluzewski W, Kowala-Piaskowska A, Mozer-Lisewska I. Figlerowicz M, et al. Eur J Pediatr. 2004 Apr;163(4-5):265-7. doi: 10.1007/s00431-004-1418-9. Epub 2004 Feb 27. Eur J Pediatr. 2004. PMID: 14991399 Clinical Trial. No abstract available.

4

Vertical transmission of hepatitis C virus infection.

Kowala-Piaskowska A, Figlerowicz M, Mozer-Lisewska I, Mazur-Melewska K, Pawełek T, Służewski W. Kowala-Piaskowska A, et al. Among authors: figlerowicz m. Hepatol Res. 2004 Nov;30(3):137-140. doi: 10.1016/j.hepres.2004.08.017. Hepatol Res. 2004. PMID: 15588778

5

Efficacy of lamivudine in the treatment of children with chronic hepatitis B.

Figlerowicz M, Kowala-Piaskowska A, Filipowicz M, Bujnowska A, Mozer-Lisewska I, Słuzewski W. Figlerowicz M, et al. Hepatol Res. 2005 Apr;31(4):217-22. doi: 10.1016/j.hepres.2005.02.003. Epub 2005 Mar 26. Hepatol Res. 2005. PMID: 15799860

6

Alterations of soluble transferrin receptor level in children with chronic hepatitis C during treatment with recombinant interferon-alpha and ribavirin.

Mozer-Lisewska I, Mania A, Kowala-Piaskowska A, Figlerowicz M, Słuzewski W. Mozer-Lisewska I, et al. Among authors: figlerowicz m. Hepatol Res. 2005 Sep;33(1):19-23. doi: 10.1016/j.hepres.2005.08.001. Epub 2005 Sep 13. Hepatol Res. 2005. PMID: 16165397

7

[Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin].

Mozer-Lisewska I, Dworacki G, Kaczmarek E, Słuzewski W, Kowala-Piaskowska A, Figlerowicz M, Kaczmarek M, Zeromski J. Mozer-Lisewska I, et al. Among authors: figlerowicz m. Przegl Epidemiol. 2005;59(2):483-9. Przegl Epidemiol. 2005. PMID: 16190557 Polish.

8

[Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C].

Kowala-Piaskowska A, Figlerowicz M, Mozer-Lisewska I, Słuzewski W. Kowala-Piaskowska A, et al. Among authors: figlerowicz m. Przegl Epidemiol. 2005;59(2):491-8. Przegl Epidemiol. 2005. PMID: 16190558 Polish.

9

[The clinical consequences of changes occurring in HCV population during the first weeks of chronic hepatitis C treatment with interferon and ribavirin].

Figlerowicz M, Formanowicz P, Kedziora P, Alejska M, Jackowiak P, Błazewicz J, Słuzewski W, Figlerowicz M. Figlerowicz M, et al. Przegl Epidemiol. 2005;59(2):581-90. Przegl Epidemiol. 2005. PMID: 16190569 Review. Polish.

10

[Current trends and first clinical studies of therapy for chronic hepatitis C in children using pegylated interferon alpha and ribavirin].

Słuzewski W, Mozer-Lisewska I, Figlerowicz M, Kowala-Piaskowska A, Słuzewska M. Słuzewski W, et al. Among authors: figlerowicz m. Przegl Epidemiol. 2005;59(2):595-9. Przegl Epidemiol. 2005. PMID: 16190571 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters